Company profile
International Stem Cell CORP CIK 1355790
Ticker
ISCO (OTC)
Industry
Pharmaceutical Preparations
Headquarters
San Diego, CA 92131
Fiscal year end
2025 (FY)
Key Financials
Revenue
$9.10M
Net income
-$418.0K
Total assets
$4.82M
Total liabilities
$4.58M
Stockholders' equity
-$4.06M
Cash & equivalents
$993.0K
Operating income
-$267.0K
Operating cash flow
$8.0K
Capital expenditures
$43.0K
Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-2.9%
Net margin
-4.6%
Free cash flow
-$35.0K
Free cash flow margin
-0.4%
Liabilities / assets
95.0%
Equity / assets
-84.2%
CapEx / revenue
0.5%
Operating cash flow / net income
-0.02×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
$9.10M
-$418.0K
$4.82M
$4.58M
-$4.06M
2024
$9.09M
-$209.0K
$5.17M
$4.80M
-$3.93M
2023
$7.79M
-$131.0K
$5.39M
$5.28M
-$4.19M
2022
$8.18M
-$331.0K
$5.14M
$5.36M
-$4.52M
2021
$7.18M
-$899.0K
$4.95M
$5.23M
-$4.59M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-17
Financials filed via
Form 10-K
filed 2026-03-30
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
San Diego, CA 92131
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:16 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.